The recalled product is the Hudson RCI Addipak, unit dose vials, 5 milliliters sterile 0.9% NaCl solution for inhalation. The units were “dispositioned for scrap” but were accidentally distributed. It is unclear why the vials did not meet sterility standards.
The FDA labeled the recall as Class I, the most serious type of notice, because use of the product could result in serious injury or death. Customers were warned about the recall in early August, according to the database.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
